Borofalan
Showing 1 - 2 of 2
Head Neck Cancer, Squamous Cell Carcinoma Trial in Koriyama (Accelerator-based BNCT with borofalan(10B))
Active, not recruiting
- Head and Neck Cancer
- Squamous Cell Carcinoma
- Accelerator-based BNCT with borofalan(10B)
-
Koriyama, Fukushima, JapanSouthern Tohoku BNCT Research Center
Jun 2, 2023
Malignant Melanoma, Angiosarcoma Trial in Chuo Ku (CICS-1 (investigational device),SPM-011(investigational drug))
Active, not recruiting
- Malignant Melanoma
- Angiosarcoma
- CICS-1 (investigational device),SPM-011(investigational drug)
-
Chuo Ku, Tokyo, JapanNational Cancer Center Hospital
Nov 6, 2022